STRATA SKIN SCIENCES, INC.— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$9M
↓-3.0% -$284Kvs FY2024 (Q4)
Gross Profit
$6M
↓-4.0% -$231Kvs FY2024 (Q4)
Operating Income
$5M
↑+7.0% +$311Kvs FY2024 (Q4)
Net Income
$4M
↑+8.5% +$330Kvs FY2024 (Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $9M | $10M |
| COGS | $4M | $4M |
| Gross Profit | $6M | $6M |
| R&D | $67K | $200K |
| SG&A | $0 | $0 |
| D&A | $821K | $1M |
| Other OpEx | $0 | $0 |
| Operating Income | $5M | $4M |
| Interest Exp. | $484K | $515K |
| Other Non-Op | $0 | $0 |
| Pretax Income | $4M | $4M |
| Tax | $12K | $0 |
| Net Income | $4M | $4M |
QuarterCharts · SEC EDGAR data · SSKN · Comparing FY2025 (Q4) vs FY2024 (Q4)